| Name | 5-(trifluoromethyl)-1H-pyrazolo[3,4-c]pyridine |
|---|---|
| Synonyms |
5-trifluoromethyl-1H-pyrazolo[3,4-c]pyridine
1H-Pyrazolo[3,4-c]pyridine, 5-(trifluoromethyl)- 5-(Trifluoromethyl)-1H-pyrazolo[3,4-c]pyridine |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 287.6±35.0 °C at 760 mmHg |
| Molecular Formula | C7H4F3N3 |
| Molecular Weight | 187.122 |
| Flash Point | 127.7±25.9 °C |
| Exact Mass | 187.035736 |
| PSA | 41.57000 |
| LogP | 1.30 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.565 |
| Hazard Codes | Xi |
|---|
|
~%
1256793-68-6 |
| Literature: NOVARTIS AG; ALTMANN, Eva; HOMMEL, Ulrich; LORTHIOIS, Edwige Liliane Jeanne; MAIBAUM, Juergen Klaus; OSTERMANN, Nils; QUANCARD, Jean; RANDL, Stefan Andreas; SIMIC, Oliver; VULPETTI, Anna; ROGEL, Olivier Patent: WO2012/93101 A1, 2012 ; Location in patent: Page/Page column 157 ; WO 2012/093101 A1 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |